CAS: 22503-72-6 Nootropics supplements IDRA-21 98% Powder IDRA 21 POWDER idra-21 powder
TDS
22503-72-6
Pharmaceutical Grade
99%
TIANJIN
Yueqi
Foil bag
2024-02-09
retatrutide,Semaglutide,tirzepatide,BPC-157,NAD,glutathione
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
IDRA 21
Other Name:IDRA 21;IDRA 21,7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazineS,S-dioxide;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE 1,1-DIOXIDE;7-CHLORO-3-METHYL-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE S,S-DIOXIDE;IDRA 21,98%;7-chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide;7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
CAS No.:22503-72-6
Molecular Formula:C8H9ClN2O2S
InChIKeys:VZRNTCHTJRLTMU-UHFFFAOYSA-N
Molecular Weight:232.69
Exact Mass:232.69
EC Number:1592732-453-0
Color/Form:Off-White to Pale Yellow
Categories:
Characteristics-
Density:
1.394±0.06 g/cm3(Predicted)
Melting Point:209 °C(Solv: acetic acid (64-19-7))
Boiling Point:405.1±55.0 °C(Predicted)
PKA:9.78±0.40(Predicted)
Critical Temperature & Pressure:Keep in dark place,Inert atmosphere,Room temperature
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
retatrutide,Semaglutide,tirzepatide,BPC-157,NAD,glutathione
-
Location:
Erqi District, Zhengzhou City
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
5-10
-
Year of Establishment:
2023
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
